Будь ласка, використовуйте цей ідентифікатор, щоб цитувати або посилатися на цей матеріал: http://dspace-ipag.com.ua/jspui/handle/123456789/916
Назва: HIGH-RISK CONGENITAL THROMBOPHILIA AND GENETIC FOLATE CYCLE DISORDERS IN PREGNANT WOMEN WITH A HISTORY OF INFERTILITY
Автори: Туманова, Л.Є.
Коломієць, О.В.
Ключові слова: genetic thrombophilia, history of endocrine and tube-peritoneal infertility, pregnancy.
Дата публікації: 5-січ-2022
Видавництво: Патологія вагінтості
Серія/номер: DOI:;10.37800/RM.1.2022.68-76
Короткий огляд (реферат): Relevance: Today, the study of hereditary thrombophilia and genetic disorders of the folate cycle in pregnant women with a history of infertility is relevant. The study aimed to analyze the frequency and structure of gene polymorphisms in high-risk congenital thrombophilia and genetic disorders of the folate cycle in pregnant women with a history of infertility. Methods: We examined 122 pregnant women aged 20 to 49. They were divided into four groups: Group (n=40) included women with a history of endocrine infertility; Group 2 (n=28) – pregnant women with tube-peritoneal infertility; Group 3 (n=36) included pregnant women with a combination of endocrine and tube-peritoneal infertility factors; Group 4 (n=18) – women without a history of infertility. Genetic analysis was carried out by real-time PCR using own Seegene – mTOCE technology for simultaneous genotyping of 6 polymorphic variants of 3 major hemostasis system genes associated with hereditary thrombophilia and folate exchange. Results: Factor 2 Prothrombin mutations in pregnant women occurred in 5% (in patients with previous endocrine infertility) to 11.1% of cases (in patients with combined infertility in the anamnesis). Factor 5 mutation was most common in women with a history of tube-peritoneal infertility and referred to as F5 Leiden, F5 P2 4070, and F5 5249. Homozygous mutations of folate cycle genes had pregnant women with infertility in the past. Conclusion: Analysis of the data obtained shows that homozygous folate cycle indicators are observed only in pregnant women with a history of infertility. The above data necessitates a timely molecular genetic examination of women with a history of infertility to prescribe corrective pathogenetic treatment and prevent the development of dangerous complications: miscarriage, fetoplacental dysfunction, a delay in intrauterine growth, or intrauterine fetal death.
URI (Уніфікований ідентифікатор ресурсу): http://dspace-ipag.com.ua/jspui/handle/123456789/916
Розташовується у зібраннях:Відділення профілактики і лікування гнійно-запальних захворювань в акушерстві

Файли цього матеріалу:
Файл Опис РозмірФормат 
Врожд.тромбофилии 2022.pdf593,72 kBAdobe PDFПереглянути/Відкрити


Усі матеріали в архіві електронних ресурсів захищені авторським правом, всі права збережені.